24/7 Customer Support

+1 718 473 0872

Generic Drug Industry

Biosimilars and their Contribution to Increasing Patient Access to Essential Medicines

  • May 2011
  • 20 pages

Download This Report Now!

We value your privacy and will never rent or sell your email address.
Privacy Policy by TRUSTe

  • Segment Coverage

    Generic Drug  

    Biosimilars  

  • Geographic Coverage

    Europe  

    Germany  

    United States  

    United Kingdom  

  • Biosimilars and their contribution to increasing patient access to essential
  • medicines 1
  • Basel, May 20, 2011 1
  • At Sandoz/Novartis, innovative and follow-on biologics are developed and
  • manufactured in the same cutting edge facilities 2
  • Biosimilars are systematically developed to match the molecular attributes of
  • the reference product 3
  • Variability is significant in original biological products 4
  • Growing demand drives costs... and threatens to limit patient access (US
  • example) 5
  • $63 billion in global biologics sales will be off patent by 2016 7
  • Europe: German example shows immediate savings from biosimilars - and huge
  • potential 8
  • UK example: Biosimilars expand access to GCSF 9
  • Genuine competition - with a ?level playing field? for all biologics - will lead
  • to increased innovation 11
  • Backup slides 12
  • Pharmacovigilance and naming 13
  • Biologics are more complex than small molecules... 15
  • Biosimilars are recognized around the world as safe and effective medicines 16
  • Biosimilars development requires substantive investment and time 17
  • Sandoz is the world leader in developing, manufacturing and commercializing
  • biosimilars 18
  • Unique position within Novartis provides powerful and entrenched - competitive
  • advantage 19
  • Sandoz biosimilars: #1 with 3 marketed products 20
  • Estimated daily treatment costs 5
  • By 2016, 7 of the top 10 pharmaceuticals worldwide will be biologics, driving up
  • healthcare costs 6
  • WW Biologics sales 7
  • EPO market in Germany: Effect of biosimilar market entry, 8
  • UK G-CSF volume growth 9
  • Sandoz drove leading market share for Zarzio in Sweden while increasing patient
  • access 10
  • What is a biosimilar (or follow-on biologic)? 14

Refine your search results

Additional Related Reports

Drug Industry

  • Lessons for Follow-on Biologics from Small Molecule Drugs
  • February 2014
    16 pages
  • Drug  

View report >

Global Generic Drug Market Forecast

  • Global Market for Generic Drugs to Reach $129 Billion in 2014
  • January 2014
    2 pages
  • Generic Drug  

    Generic Drugs  

    Generics  

  • World  

    Europe  

    India  

View report >

Generic Drug Industry

  • Long Term Follow-up after Imatinib Cessation for Patients in Dee...
  • January 2014
    14 pages
  • Generic Drug  

View report >

Purchase Reports From Reputable Market Research Publishers

Generics Market Overview in Europe

Generics Market Overview in Europe

  • $ 350
  • Industry report
  • August 2013
  • by MarketLine

It includes data on industry size and key market segments, plus textual and graphical analysis of the major trends and drivers and key competitors, main industry players and demographic information. What's ...

Analyzing the Global Generics Industry 2014

Analyzing the Global Generics Industry 2014

  • $ 1 750
  • Industry report
  • May 2014
  • by Aruvian's R'search

In recent times there has been a growing focus on the generic drugs industry worldwide. The patent expiry of leading drugs in recent years and also the upcoming patent expiries has put a focus on the global ...

Transition at Teva: Blockbuster drug Copaxone to lose patent protection in 2014

Transition at Teva: Blockbuster drug Copaxone to lose patent protection in 2014

  • $ 495
  • Industry report
  • April 2014
  • by MarketLine

Introduction In October 2013, Teva announced that it would be cutting approximately 10% of the workforce in order to cut costs. Later that month, it announced the departure of its CEO of just 18 months, ...

Global Markets For Generic Drugs

January 2014 $ 6 650

Global Hyaluronic Market 2012-2016

October 2013 $ 2 500

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.